{
  "main_header": {
    "sid": 1292741,
    "name": "Cartesian Therapeutics, Inc.",
    "stock_name": "Cartesian Therapeutics, Inc.",
    "full_name": "Cartesian Therapeutics, Inc.",
    "name_url": "stocks-analysis/cartesian-therapeutics-inc",
    "exchange": 210,
    "exchangecode": "NAS",
    "country_id": 2,
    "currency": "USD",
    "cmp": "7.22",
    "chg": -0.14,
    "chgp": "-1.9%",
    "dir": -1,
    "prev_price": "7.36",
    "mcapval": "264.96",
    "mcap": "Micro Cap",
    "scripcode": "",
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 2320,
    "indexname": "S&P 500",
    "isin": "US8162121045",
    "curr_date": "Dec 19",
    "curr_time": "",
    "bse_nse_vol": "595.25 k",
    "exc_status": "Active",
    "traded_date": "Dec 19, 2025",
    "traded_date_str": "2025 12 19",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/cartesian-therapeutics-inc-1292741-210&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Cartesian Therapeutics Hits New 52-Week Low at $5.98 Amidst Declining Performance",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/cartesian-therapeutics-hits-new-52-week-low-at-598-amidst-declining-performance-3680220",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/CartesianTherap_priceRelatedfactors_3680220.png",
        "date": "2025-11-07 16:16:14",
        "description": "Cartesian Therapeutics, Inc. has reached a new 52-week low, reflecting a significant decline in performance over the past year. The company, with a market capitalization of USD 265 million, faces financial pressures, including rising raw material costs and a lack of reported results, raising concerns about its operational stability."
      },
      {
        "title": "Cartesian Therapeutics Hits 52-Week Low at $7.67 Amidst Significant Decline",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/cartesian-therapeutics-hits-52-week-low-at-767-amidst-significant-decline-3674081",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/CartesianTherap_priceRelatedfactors_3674081.png",
        "date": "2025-11-05 16:59:07",
        "description": "Cartesian Therapeutics, Inc. has reached a new 52-week low, reflecting a significant decline from its previous high. The company has struggled with a substantial drop in stock value and has faced challenges such as rising raw material costs and a lack of recent performance reports, raising concerns about its stability."
      }
    ],
    "total": 6,
    "sid": "1292741",
    "stock_news_url": "https://www.marketsmojo.com/news/cartesian-therapeutics-inc-1292741"
  },
  "announcements": "",
  "corporate_actions": {
    "msg": "No corporate action Found"
  }
}

News and Views

Cartesian Therapeutics Hits New 52-Week Low at $5.98 Amidst Declining Performance

2025-11-07 16:16:14

Cartesian Therapeutics, Inc. has reached a new 52-week low, reflecting a significant decline in performance over the past year. The company, with a market capitalization of USD 265 million, faces financial pressures, including rising raw material costs and a lack of reported results, raising concerns about its operational stability.

Read More

Cartesian Therapeutics Hits 52-Week Low at $7.67 Amidst Significant Decline

2025-11-05 16:59:07

Cartesian Therapeutics, Inc. has reached a new 52-week low, reflecting a significant decline from its previous high. The company has struggled with a substantial drop in stock value and has faced challenges such as rising raw material costs and a lack of recent performance reports, raising concerns about its stability.

Read More

View All News